BioCentury
ARTICLE | Company News

Alnylam, Isis, Stanford University deal

September 19, 2005 7:00 AM UTC

Separately, ALNY and ISIS co-exclusively licensed IP from the university that covers the microRNA (miRNA) gene miR-122, which is required for HCV replication. Last year, the companies partnered to dev...